Janelle Davison
Optometrist · Smyrna, GANPI 1053475855
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 43.5% of the total. Among optometrist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $462.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$86K
- Alcon$72K
- Oyster Point Pharma, Inc.$30K
- AbbVie$2K
- Novartis$2K
- Bausch & Lomb Americas Inc.$2K
- plus $4K from 18 others
What the payments were for
- Consulting fees$96,10048%
- Speaking & faculty fees$69,74435%
- Travel & lodging$20,88611%
- Food & beverage$11,9616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 113 | $86,414 |
| Alcon | 143 | $72,212 |
| Oyster Point Pharma, Inc. | 61 | $30,372 |
| AbbVie | 13 | $2,122 |
| Novartis | 16 | $1,728 |
| Bausch & Lomb Americas Inc. | 27 | $1,661 |
| Sight Sciences, Inc. | 8 | $1,031 |
| Kala Pharmaceuticals, Inc. | 4 | $973 |
| Harrow Eye, LLC | 9 | $403 |
| Sun Pharmaceutical Industries Inc. | 3 | $292 |
| Johnson & Johnson Vision Care, Inc. | 9 | $269 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $223 |
| Amgen(2 entities) | 4 | $195 |
| Carl Zeiss Meditec USA, Inc. | 6 | $159 |
| Synergeyes, Inc. | 1 | $155 |
| Merakris Therapeutics, Inc. | 1 | $125 |
| LKC Technologies, Inc. | 1 | $96 |
| Glaukos Corporation | 1 | $84 |
| Immunogen, Inc. | 1 | $48 |
| Tearlab Corp | 1 | $36 |
| Dompe US, Inc. | 2 | $33 |
| Lombart Brothers, Inc. | 1 | $30 |
| Biotissue Holdings Inc. | 1 | $16 |
| Coopervision Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$62,334
- TYRVAYA$28,191
- TOTAL30$27,326
- DAILIES TOTAL1$22,221
- Precision 1$19,798
- Precision7$18,402
- Precision 7$13,810
- TRYPTYR$8,792
- XIIDRA$2,394
- Ryzumvi$1,140
- AIR OPTIX$1,062
- EYSUVIS$911
- TEARCARE SYSTEM$750
- Systane$640
- Dailies Aqua Comfort Plus$603
- MIEBO$366
- Pataday$320
- DAILIES$315
- DAILIES TOTAL1 Multifocal$300
- CEQUA$280
How this compares
$198,691 in reported general payments places this provider in the 95th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $22,413 |
| TyrvayaVarenicline Tartrate | 18 | $13,349 |
| Latanoprost | 39 | $229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $2,122 | $22,41317 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $30,372 | $13,34918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,285 optometrist providers in Georgia.
Other optometrist in Smyrna
- Joshua JohnstonAtlanta$993K
- John WomackCanton$931K
- Naheed AhmadRoswell$296K
- Scott MoscowRoswell$278K
- Stephen SummerowPerry$222K
- Keyle BrownDawsonville$182K
- Nacondus GambleFort Stewart$175K
- Amber ZaunbrecherAtlanta$99K
- Jeffrey CofieWarner Robins$93K
- Emily LoveAtlanta$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.